These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28079589)

  • 1. In Vogue: Ketamine for Neuroprotection in Acute Neurologic Injury.
    Bell JD
    Anesth Analg; 2017 Apr; 124(4):1237-1243. PubMed ID: 28079589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Starting ketamine for neuroprotection earlier than its current use as an anesthetic/antiepileptic drug late in refractory status epilepticus.
    Fujikawa DG
    Epilepsia; 2019 Mar; 60(3):373-380. PubMed ID: 30785224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of ketamine as a neuroprotective agent following cardiac arrest: A scoping review of current literature.
    Ornowska M; Wormsbecker A; Andolfatto G; Leung TS; Khan I; Medvedev G
    CNS Neurosci Ther; 2023 Jan; 29(1):104-110. PubMed ID: 36184822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ketamine revisited].
    Marchant N; Joris J
    Rev Med Liege; 2010 Jan; 65(1):29-34. PubMed ID: 20222506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine: repurposing and redefining a multifaceted drug.
    Potter DE; Choudhury M
    Drug Discov Today; 2014 Dec; 19(12):1848-54. PubMed ID: 25224017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug.
    Aroni F; Iacovidou N; Dontas I; Pourzitaki C; Xanthos T
    J Clin Pharmacol; 2009 Aug; 49(8):957-64. PubMed ID: 19546251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroprotection by ketamine and dopamine-saving drugs in severe craniocerebral trauma at exacerbation and in the treatment of apallic syndrome].
    Vereshchagin EI; Tarasov RS; Astrakov SV; Lokotkova OV; Egorov AV; Volkov SG; Vereshchagin IP
    Anesteziol Reanimatol; 2004; (4):54-6. PubMed ID: 15468560
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketamine as a neuroprotective and anti-inflammatory agent in children undergoing surgery on cardiopulmonary bypass: a pilot randomized, double-blind, placebo-controlled trial.
    Bhutta AT; Schmitz ML; Swearingen C; James LP; Wardbegnoche WL; Lindquist DM; Glasier CM; Tuzcu V; Prodhan P; Dyamenahalli U; Imamura M; Jaquiss RD; Anand KJ
    Pediatr Crit Care Med; 2012 May; 13(3):328-37. PubMed ID: 21926656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on the Basic and Clinical Science of Ketamine Analgesia.
    Doan LV; Wang J
    Clin J Pain; 2018 Nov; 34(11):1077-1088. PubMed ID: 29927768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine for Refractory Status Epilepticus: A Systematic Review.
    Rosati A; De Masi S; Guerrini R
    CNS Drugs; 2018 Nov; 32(11):997-1009. PubMed ID: 30232735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why ketamine.
    Coles L; Rosenthal ES; Bleck TP; Elm J; Zehtabchi S; Chamberlain J; Cloyd J; Shinnar S; Silbergleit R; Kapur J
    Epilepsy Behav; 2023 Apr; 141():109066. PubMed ID: 36609129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ketamine in uncontrolled acute and procedural pain.
    Chumbley G
    Nurs Stand; 2010 Dec 15-2011 Jan 4; 25(15-17):35-7. PubMed ID: 21309429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical neuroprotective actions of xenon and possible implications for human therapeutics: a narrative review.
    Maze M
    Can J Anaesth; 2016 Feb; 63(2):212-26. PubMed ID: 26507536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine-A Narrative Review of Its Uses in Medicine.
    Radvansky BM; Puri S; Sifonios AN; Eloy JD; Le V
    Am J Ther; 2016; 23(6):e1414-e1426. PubMed ID: 25923225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of ketamine for analgesia.
    Ben-Ari A; Lewis MC; Davidson E
    J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ketamine in the therapy of chronic pain and depression].
    Jaksch W; Likar R; Aigner M
    Wien Med Wochenschr; 2019 Nov; 169(15-16):367-376. PubMed ID: 30980201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of neuroprotective treatment efficiency using a HRMAS NMR-based statistical model of refractory status epilepticus on mouse: a metabolomic approach supported by histology.
    Fauvelle F; Carpentier P; Dorandeu F; Foquin A; Testylier G
    J Proteome Res; 2012 Jul; 11(7):3782-95. PubMed ID: 22621346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine for the treatment of chronic non-cancer pain.
    Noppers I; Niesters M; Aarts L; Smith T; Sarton E; Dahan A
    Expert Opin Pharmacother; 2010 Oct; 11(14):2417-29. PubMed ID: 20828267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain.
    Dahan A; Olofsen E; Sigtermans M; Noppers I; Niesters M; Aarts L; Bauer M; Sarton E
    Eur J Pain; 2011 Mar; 15(3):258-67. PubMed ID: 20638877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brain injury -- protection for the nerve in severe head injury].
    Sportverletz Sportschaden; 2012 Dec; 26(4):184. PubMed ID: 23296505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.